Christopher Bernard

Christopher M.
Bernard currently works at DiamiR Biosciences Corp., as Independent Director.
Mr. Bernard also formerly worked at Curetis USA, Inc., as President & Chief Executive Officer, Applied BioCode, Inc., as Chief Executive Officer from 2022 to 2024, OncoGenesis, Inc., as Chief Executive Officer from 2018 to 2019, Cytyc Corp., as Regional Director-Business from 1995 to 2005, OpGen, Inc., as Director from 2020 to 2022, Genalyte, Inc., as Director from 2020 to 2022, Inceptor Bio LLC, as Director from 2020 to 2022, Fastback Bio LLC, as Director from 2020 to 2022, Biovision Diagnostics LLC, as Director from 2020 to 2022, Ubiquitome, Inc., as Non-Executive Director from 2020 to 2022, Abaxis, Inc., as Vice President-Sales & Marketing, Metabolon, Inc., as Senior VP-Sales & Marketing & Officer, Curetis NV, as Executive Vice President-Global Sales from 2017 to 2018, and Epic Sciences, Inc., as Chief Commercial Officer from 2015 to 2016.
Mr. Bernard received his undergraduate degree from Hiram College.